A rod bacterium-like magnetic polymer micelle for strongly enhancing selective accumulation and internalization of nanocarriers

2017 ◽  
Vol 5 (25) ◽  
pp. 4943-4954 ◽  
Author(s):  
Yuqian Gao ◽  
Jingya Zhao ◽  
Xiaobin Zhang ◽  
Xiao Wei ◽  
Xiang Xiong ◽  
...  

The precise and highly efficient delivery of a therapeutic agent with nanocarriers to a tumor site to achieve excellent therapeutic efficacy remains a major challenge in cancer chemotherapy.

2015 ◽  
Vol 3 (39) ◽  
pp. 7707-7717 ◽  
Author(s):  
Jinyan Lin ◽  
Yanxiu Li ◽  
Yang Li ◽  
Fei Cui ◽  
Fei Yu ◽  
...  

Self-targeted, bacillus-shaped, and controlled-release methotrexate prodrug polymeric nanoparticles for highly efficient cancer chemotherapy: more elongated is better.


2020 ◽  
Vol 11 (9) ◽  
pp. 591-603
Author(s):  
Wei He ◽  
Annie Turkeshi ◽  
Xiaotong Li ◽  
Hongwei Zhang

MicroRNAs (miRNAs) hold the potential to boost therapeutic efficacy and/or reverse drug resistance associated with traditional cancer chemotherapy. Both miRNA mimics and inhibitors have been explored in cancer therapy. Systemic co-delivery of chemotherapeutics and miRNA therapeutics represents an attractive treatment approach, but safe and efficient delivery systems are greatly needed. The regulatory approval of Onpattro® paved the way for lipid-based nanoparticles to deliver RNA therapeutics in different settings, including in combination with chemotherapeutics to treat cancer. In this Special Report, we discuss the significance of systemic co-delivery of chemotherapeutics and miRNA therapeutics for cancer therapy and highlight the representative examples of this strategy using lipid-based nanoparticles. We also present outstanding roadblocks to clinical translation and provide the latest perspectives.


2016 ◽  
Vol 11 (1) ◽  
Author(s):  
Shichao Wu ◽  
Xiangrui Yang ◽  
Yang Li ◽  
Hongjie Wu ◽  
Yu Huang ◽  
...  

2021 ◽  
Author(s):  
Yong Yao ◽  
Danni Jing ◽  
Jianan Zhang ◽  
Youyou Huang ◽  
Xiru Qin ◽  
...  

Featuring high therapeutic efficacy, biocompatibility, and biosafety, gas therapy as a burgeoning and promising research field has attracted considerable attention in biomedicine. However, the lack of the tumor site accumulation...


2021 ◽  
Author(s):  
Yue Yan ◽  
Binlong Chen ◽  
Qingqing Yin ◽  
Zenghui Wang ◽  
Ye Yang ◽  
...  

Abstract Efficient delivery of payload to intracellular targets has been identified as the central principle for nanomedicine development, while the extracellular targets are equally important for cancer treatment. Notably, the contribution of extracellularly distributed nanoparticles to therapeutic outcome is far from being understood. Herein, we develop a pH/light dual-responsive monochromatic ratiometric imaging nanoparticle (MRIN), which functions through sequentially lighting up the intracellular and extracellular fluorescence signals by acidic endocytic pH and near-infrared light. Enabled by MRIN nanotechnology, we accurately quantify the extracellular and intracellular distribution of nanoparticles in several tumor models, which account for 65-80% and 20-35% of total tumor exposure, respectively. Given that the majority of nanoparticles are trapped in extracellular regions, we successfully dissect the contribution of extracellularly distributed nanophotosensitizer to therapeutic efficacy, thereby maximize the treatment outcome. Our study provides key strategies to precisely quantify nanocarrier microdistribtion and engineer multifunctional nanomedicines for efficient theranostics.


2019 ◽  
Vol 7 (27) ◽  
pp. 4319-4327 ◽  
Author(s):  
Sheng-Lei Hou ◽  
Shuang-Shuang Chen ◽  
Zhang-Jun Huang ◽  
Qing-Hua Lu

A drug self-framed delivery system (DSFDS) with dual-stimuli-responsive drug release and superhigh drug loaded capacity for efficient cancer chemotherapy is proposed.


2019 ◽  
Vol 7 (8) ◽  
pp. 3510-3518
Author(s):  
Ying Ye ◽  
Rong Jin ◽  
Xiaoxin Hu ◽  
Juhua Zhuang ◽  
Wei Xia ◽  
...  

Bioreducible poly(urethane amine)s can be designed and optimized for highly efficient delivery in vitro of DNA or SiRNA into adult or embryonic stem cells with low cytotoxicity.


2015 ◽  
Vol 2015 ◽  
pp. 1-10 ◽  
Author(s):  
Jeffrey K. Actor

There is great need for a therapeutic that would limit tuberculosis related pathology and thus curtail spread of disease between individuals by establishing a “firebreak” to slow transmission. A promising avenue to increase current therapeutic efficacy may be through incorporation of adjunct components that slow or stop development of aggressive destructive pulmonary pathology. Lactoferrin, an iron-binding glycoprotein found in mucosal secretions and granules of neutrophils, is just such a potential adjunct therapeutic agent. The focus of this review is to explore the utility of lactoferrin to serve as a therapeutic tool to investigate “disruption” of the mycobacterial granuloma. Proposed concepts for mechanisms underlying lactoferrin efficacy to control immunopathology are supported by data generated based onin vivomodels using nonpathogenic trehalose 6,6′-dimycolate (TDM, cord factor).


Sign in / Sign up

Export Citation Format

Share Document